Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

QUIDEL CORPORATION

(QDEL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Quidel : Settles Litigation With Beckman Coulter

07/26/2021 | 09:45am EDT


ę MT Newswires 2021
All news about QUIDEL CORPORATION
09/01QUIDEL : to Market COVID-19 Home Test Kits at CVS Pharmacies, Online Next Week
MT
09/01QUIDEL : to Bring QuickVue« At-Home OTC COVID-19 Tests To CVS Pharmacy
BU
09/01Quidel to Bring QuickVue« At-Home OTC COVID-19 Tests To CVS Pharmacy
CI
08/27QUIDEL : U.S. COVID-19 tests again in short supply as infections soar, schools r..
RE
08/10Cardinal Health Partners With Abbott, Quidel to Provide COVID-19 Tests
MT
08/10QUIDEL : LivLyme Foundation Founder Olivia Goodreau to Discuss Perils of Lyme Di..
BU
08/10PRESS RELEASE : LivLyme Foundation Founder Olivia Goodreau to Discuss Perils of ..
DJ
08/10Cardinal Health, Inc. Partners with Abbott Laboratories and Quidel Corporatio..
CI
08/06SECTOR UPDATE : Health Care Stocks Largely Struggle Friday
MT
08/06SECTOR UPDATE : Health Care Stocks Drifting Lower on Friday
MT
More news
Analyst Recommendations on QUIDEL CORPORATION
More recommendations
Financials (USD)
Sales 2021 935 M - -
Net income 2021 276 M - -
Net cash 2021 847 M - -
P/E ratio 2021 23,0x
Yield 2021 -
Capitalization 6 013 M 6 013 M -
EV / Sales 2021 5,52x
EV / Sales 2022 7,31x
Nbr of Employees 1 370
Free-Float 87,8%
Chart QUIDEL CORPORATION
Duration : Period :
Quidel Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUIDEL CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 144,44 $
Average target price 148,00 $
Spread / Average Target 2,46%
EPS Revisions
Managers and Directors
Douglas C. Bryant President, Chief Executive Officer & Director
Randall J. Steward Chief Financial & Accounting Officer
Kenneth F. Buechler Chairman
Werner Kroll Senior Vice President-Research & Development
Karen C. Gibson SVP-Information Systems & Business Transformation
Sector and Competitors
1st jan.Capi. (M$)
QUIDEL CORPORATION-19.60%6 013
DANAHER CORPORATION46.42%231 303
THERMO FISHER SCIENTIFIC20.86%220 488
INTUITIVE SURGICAL, INC.26.39%123 038
SIEMENS HEALTHINEERS AG37.68%76 323
EDWARDS LIFESCIENCES CORPORATION32.65%75 229